Year |
Citation |
Score |
2022 |
Yang EY, Howard GR, Brock A, Yankeelov TE, Lorenzo G. Mathematical characterization of population dynamics in breast cancer cells treated with doxorubicin. Frontiers in Molecular Biosciences. 9: 972146. PMID 36172049 DOI: 10.3389/fmolb.2022.972146 |
0.751 |
|
2022 |
Howard GR, Jost TA, Yankeelov TE, Brock A. Quantification of long-term doxorubicin response dynamics in breast cancer cell lines to direct treatment schedules. Plos Computational Biology. 18: e1009104. PMID 35358172 DOI: 10.1371/journal.pcbi.1009104 |
0.722 |
|
2020 |
Song PN, Mansur A, Dugger KJ, Davis TR, Howard G, Yankeelov TE, Sorace AG. CD4 T-cell immune stimulation of HER2 + breast cancer cells alters response to trastuzumab in vitro. Cancer Cell International. 20: 544. PMID 33292267 DOI: 10.1186/s12935-020-01625-w |
0.369 |
|
2020 |
Johnson KE, Howard GR, Morgan D, Brenner EA, Gardner AL, Durrett RE, Mo W, Al'Khafaji A, Sontag ED, Jarrett AM, Yankeelov TE, Brock A. Integrating transcriptomics and bulk time course data into a mathematical framework to describe and predict therapeutic resistance in cancer. Physical Biology. 18: 016001. PMID 33215611 DOI: 10.1088/1478-3975/Abb09C |
0.538 |
|
2019 |
Johnson KE, Howard G, Mo W, Strasser MK, Lima EABF, Huang S, Brock A. Cancer cell population growth kinetics at low densities deviate from the exponential growth model and suggest an Allee effect. Plos Biology. 17: e3000399. PMID 31381560 DOI: 10.1371/Journal.Pbio.3000399 |
0.72 |
|
2018 |
Howard GR, Johnson KE, Rodriguez Ayala A, Yankeelov TE, Brock A. A multi-state model of chemoresistance to characterize phenotypic dynamics in breast cancer. Scientific Reports. 8: 12058. PMID 30104569 DOI: 10.1038/S41598-018-30467-W |
0.772 |
|
2017 |
Johnson KE, Howard G, Brock A, Yankeelov T. Abstract LB-011: Experimentally derived multi-state model of chemoresistance to characterize phenotypic dynamics in breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-011 |
0.741 |
|
Show low-probability matches. |